Tissino E, Zucchetto A, Pozzo F, Hartmann T, Gattei V
Methods Mol Biol. 2025; 2909:45-60.
PMID: 40029514
DOI: 10.1007/978-1-0716-4442-3_4.
Tissino E, Gaglio A, Nicolo A, Pozzo F, Bittolo T, Rossi F
Leukemia. 2024; 38(10):2127-2140.
PMID: 39143370
PMC: 11436378.
DOI: 10.1038/s41375-024-02376-7.
Candelaria G, Antunes A, Pastorino A, Dorna M, Zanardo E, Dias A
J Pediatr Genet. 2024; 12(4):348-351.
PMID: 38162163
PMC: 10756723.
DOI: 10.1055/s-0041-1733948.
Zhang L, Cao Y, Dai X, Zhang X
Front Pharmacol. 2022; 13:1065029.
PMID: 36386145
PMC: 9664064.
DOI: 10.3389/fphar.2022.1065029.
Nguyen K, Juillard P, Hawke S, Grau G, Marsh-Wakefield F
J Clin Med. 2022; 11(21).
PMID: 36362494
PMC: 9658536.
DOI: 10.3390/jcm11216266.
Key immune-related gene ITGB2 as a prognostic signature for acute myeloid leukemia.
Wei J, Huang X, Huang Y, Xiong M, Yao X, Huang Z
Ann Transl Med. 2021; 9(17):1386.
PMID: 34733938
PMC: 8506550.
DOI: 10.21037/atm-21-3641.
Recent Advances in BTK Inhibitors for the Treatment of Inflammatory and Autoimmune Diseases.
Zhang D, Gong H, Meng F
Molecules. 2021; 26(16).
PMID: 34443496
PMC: 8399599.
DOI: 10.3390/molecules26164907.
Bidirectional feedback between BCR signaling and actin cytoskeletal dynamics.
Bhanja A, Rey-Suarez I, Song W, Upadhyaya A
FEBS J. 2021; 289(15):4430-4446.
PMID: 34124846
PMC: 8669062.
DOI: 10.1111/febs.16074.
Zanubrutinib (BGB-3111), a Second-Generation Selective Covalent Inhibitor of Bruton's Tyrosine Kinase and Its Utility in Treating Chronic Lymphocytic Leukemia.
Rhodes J, Mato A
Drug Des Devel Ther. 2021; 15:919-926.
PMID: 33688166
PMC: 7936706.
DOI: 10.2147/DDDT.S250823.
Activated Human Memory B Lymphocytes Use CR4 (CD11c/CD18) for Adhesion, Migration, and Proliferation.
Nagy-Balo Z, Kiss R, Menge A, Bodor C, Bajtay Z, Erdei A
Front Immunol. 2020; 11:565458.
PMID: 33133077
PMC: 7550640.
DOI: 10.3389/fimmu.2020.565458.
Host receptors: the key to establishing cells with broad viral tropism for vaccine production.
Dai X, Zhang X, Ostrikov K, Abrahamyan L
Crit Rev Microbiol. 2020; 46(2):147-168.
PMID: 32202955
PMC: 7113910.
DOI: 10.1080/1040841X.2020.1735992.
Fc Receptor-Like 6 (FCRL6) Discloses Progenitor B Cell Heterogeneity That Correlates With Pre-BCR Dependent and Independent Pathways of Natural Antibody Selection.
Honjo K, Won W, King R, Ianov L, Crossman D, Easlick J
Front Immunol. 2020; 11:82.
PMID: 32117244
PMC: 7033751.
DOI: 10.3389/fimmu.2020.00082.
Epigenome-wide association study reveals methylation pathways associated with childhood allergic sensitization.
Peng C, van Meel E, Cardenas A, Rifas-Shiman S, Sonawane A, Glass K
Epigenetics. 2019; 14(5):445-466.
PMID: 30876376
PMC: 6557548.
DOI: 10.1080/15592294.2019.1590085.
Monitoring and Management of Toxicities of Novel B Cell Signaling Agents.
Rhodes J, Mato A, Sharman J
Curr Oncol Rep. 2018; 20(6):49.
PMID: 29644450
DOI: 10.1007/s11912-018-0694-x.
Functional and clinical relevance of VLA-4 (CD49d/CD29) in ibrutinib-treated chronic lymphocytic leukemia.
Tissino E, Benedetti D, Herman S, Ten Hacken E, Ahn I, Chaffee K
J Exp Med. 2018; 215(2):681-697.
PMID: 29301866
PMC: 5789417.
DOI: 10.1084/jem.20171288.
NLR Nod1 signaling promotes survival of BCR-engaged mature B cells through up-regulated Nod1 as a positive outcome.
Hayakawa K, Formica A, Zhou Y, Ichikawa D, Asano M, Li Y
J Exp Med. 2017; 214(10):3067-3083.
PMID: 28878001
PMC: 5626402.
DOI: 10.1084/jem.20170497.
Substrate stiffness governs the initiation of B cell activation by the concerted signaling of PKCβ and focal adhesion kinase.
Shaheen S, Wan Z, Li Z, Chau A, Li X, Zhang S
Elife. 2017; 6.
PMID: 28755662
PMC: 5536945.
DOI: 10.7554/eLife.23060.
DOCK8 regulates signal transduction events to control immunity.
Kearney C, Randall K, Oliaro J
Cell Mol Immunol. 2017; 14(5):406-411.
PMID: 28366940
PMC: 5423093.
DOI: 10.1038/cmi.2017.9.
A novel 3D mesenchymal stem cell model of the multiple myeloma bone marrow niche: biologic and clinical applications.
Jakubikova J, Cholujova D, Hideshima T, Gronesova P, Soltysova A, Harada T
Oncotarget. 2016; 7(47):77326-77341.
PMID: 27764795
PMC: 5357212.
DOI: 10.18632/oncotarget.12643.
Leukocyte arrest: Biomechanics and molecular mechanisms of β2 integrin activation.
Fan Z, Ley K
Biorheology. 2015; 52(5-6):353-77.
PMID: 26684674
PMC: 4869873.
DOI: 10.3233/BIR-15085.